ESSA Pharma Inc.

NasdaqCM:EPIX Stock Report

Mkt Cap: US$127.9m

ESSA Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:EPIX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Dec 22BuyUS$7,974David ParkinsonIndividual3,067US$2.60
30 Dec 22BuyUS$21,585David WoodIndividual8,302US$2.60
22 Dec 22BuyUS$51,067David ParkinsonIndividual21,367US$2.39
21 Dec 22SellUS$729,052Franklin BergerIndividual272,840US$3.00
27 Oct 22BuyUS$8,219,600Bellevue Asset Management AGCompany2,000,000US$4.50
18 Jul 22BuyUS$946,740Bellevue Asset Management AGCompany300,000US$3.16
15 Jul 22BuyUS$1,726,226Bellevue Asset Management AGCompany588,869US$3.13
11 Jul 22BuyUS$11,438,000BVF Partners L.P.Company4,300,000US$2.66
30 Jun 22BuyUS$14,456David ParkinsonIndividual4,887US$2.96
27 Apr 22SellUS$146,925Bellevue Asset Management AGCompany25,100US$5.85

Insider Trading Volume

Insider Buying: EPIX insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of EPIX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders919,1982.1%
General Public1,488,2243.4%
Public Companies1,675,0003.8%
Hedge Funds18,983,50043.1%
Institutions21,026,45247.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 93.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.84%
BVF Partners L.P.
8,748,629$25.4m136.54%0.9%
17.87%
Bellevue Asset Management AG
7,879,583$22.9m33.58%0.23%
8.72%
PFM Health Sciences, LP
3,844,332$11.1m160.06%0.42%
8.5%
Avidity Partners Management, L.P.
3,750,000$10.9m52.44%0.22%
5.99%
Soleus Capital Management, L.P.
2,640,539$7.7m-36.66%0.9%
4.77%
Morgan Stanley, Investment Banking and Brokerage Investments
2,105,213$6.1m-42.63%no data
3.8%
Pfizer Inc.
1,675,000$4.9m0%no data
3.54%
Eventide Asset Management, LLC
1,561,251$4.5m-53.61%0.08%
2.97%
RTW Investments, LP
1,311,294$3.8m-50.28%0.07%
2.36%
Adage Capital Management, L.P.
1,042,531$3.0m0%0.01%
1.55%
Franklin Berger
684,404$2.0m-28.5%no data
1.45%
OrbiMed Advisors LLC
640,645$1.9m0%0.03%
1.37%
Frazier Life Sciences Management, LP
605,141$1.8m-12.67%0.11%
1.34%
Medical Strategy GmbH, Asset Management Arm
592,529$1.7m0%0.11%
1.19%
Rock Springs Capital Management LP
524,944$1.5m0%0.04%
1.13%
D. E. Shaw & Co., L.P.
499,833$1.4m46.74%no data
0.95%
Candriam Luxembourg S.A.
417,532$1.2m-26.41%no data
0.92%
Millennium Management LLC
406,761$1.2m24.49%no data
0.92%
Mpm Oncology Impact Management, L.P.
405,700$1.2m-38.61%0.28%
0.87%
Woodline Partners LP
382,282$1.1m0%0.01%
0.85%
Rhenman & Partners Asset Management AB
375,000$1.1m0%0.12%
0.79%
Two Sigma Investments, LP
347,758$1.0m575.84%no data
0.78%
Two Sigma Advisers, LP
342,400$993.0k570.06%no data
0.74%
Omega Fund Management, LLC
328,196$951.8k0%0.31%
0.54%
Walleye Capital LLC
237,153$687.7k127.17%0.01%